Quantification of patient-derived 3D cancer spheroids in high content screening images

被引:0
|
作者
Kang, Mi-Sun [1 ]
Rhee, Seon-Min [2 ]
Seo, Ji-Hyun [1 ]
Kim, Myoung-Hee [1 ]
机构
[1] Ewha Womans Univ, Dept Comp Sci & Engn, Seoul, South Korea
[2] Samsung Adv Inst Technol, Suwon, South Korea
关键词
Image quantification; patient-derived; 3D spheroids; high content screening; cancer cell;
D O I
10.1117/12.2250594
中图分类号
O43 [光学];
学科分类号
070207 ; 0803 ;
摘要
We present a cell image quantification method for image-based drug response prediction from patient-derived glioblastoma cells. Drug response of each person differs at the cellular level. Therefore, quantification of a patient-derived cell phenotype is important in drug response prediction. We performed fluorescence microscopy to understand the features of patient-derived 3D cancer spheroids. A 3D cell culture simulates the in-vivo environment more closely than 2D adherence culture, and thus, allows more accurate cell analysis. Furthermore, it allows assessment of cellular aggregates. Cohesion is an important feature of cancer cells. In this paper, we demonstrate image-based quantification of cellular area, fluorescence intensity, and cohesion. To this end, we first performed image stitching to create an image of each well of the plate with the same environment. This image shows colonies of various sizes and shapes. To automatically detect the colonies, we used an intensity based classification algorithm. The morphological features of each cancer cell colony were measured. Next, we calculated the location correlation of each colony that is appeal of the cell density in the same well environment. Finally, we compared the features for drug-treated and untreated cells. This technique could potentially be applied for drug screening and quantification of the effects of the drugs.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Automation and high content imaging of 3D triple negative breast cancer patient-derived tumoroids assay for compound screening
    Sirenko, Oksana
    Lim, Angeline
    Brock, Courtney K.
    Nikolov, Katya
    Olsen, Cathy
    Cromwell, Evan F.
    Matossian, Margarite D.
    Burow, Matthew E.
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [2] Preclinical testing of therapeutic biologics using patient-derived 3D spheroids
    Lassahn, Katy A.
    Elrod, Ashley K.
    Carlson, Aaron L.
    Dance, Natalie A.
    Millard, Melissa
    Wick, Michael J.
    DesRochers, Teresa M.
    Appleton, Kathryn M.
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [3] Phenotypic feature quantification of patient derived 3D cancer spheroids in fluorescence microscopy image
    Kang, Mi-Sun
    Rhee, Seon-Min
    Seo, Ji-Hyun
    Kim, Myoung-Hee
    [J]. MEDICAL IMAGING 2017: BIOMEDICAL APPLICATIONS IN MOLECULAR, STRUCTURAL, AND FUNCTIONAL IMAGING, 2017, 10137
  • [4] PARP inhibition in combination with pembrolizumab enhances cytotoxicity in ovarian cancer patient-derived 3D spheroids
    Appleton, Kathryn M.
    Elrod, Ashley
    Shuford, Stephen
    DesRochers, Teresa M.
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [5] Patient-derived spheroids and patient-derived organoids simulate evolutions of lung cancer
    Surina, Kazutaka
    Tanggis
    Suzuki, Tomoko
    Hisata, Shu
    Fujita, Kazutaka
    Fujiwara, Satomi
    Liu, Fangyuan
    Fukushima, Noriyoshi
    Suzuki, Takuji
    Mato, Naoko
    Hagiwara, Koichi
    [J]. HELIYON, 2023, 9 (03)
  • [6] Development of automated 3D high-throughput drug screening platform for patient-derived breast cancer organoids
    Kim, Jungeun
    Kim, Hoe Suk
    Kim, Ga Yeon
    Park, Kyung Hyeun
    Ryu, Seung Yeon
    Lee, Sangeun
    Lee, Dong Woo
    Ku, Bosung
    Lee, Han-Byoel
    Han, Wonshik
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [7] MEASURING IMMUNE CHECKPOINT INHIBITOR EFFICACY USING PRIMARY PATIENT-DERIVED 3D SPHEROIDS
    Appleton, Kathryn
    Lassahn, Katy
    Elrod, Ashley
    DesRochers, Tessa
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A305 - A305
  • [8] Development of spheroids derived from tumor biopsies and patient-derived xenografts using magnetic 3D bioprinting
    Tseng, Hubert
    Gage, Jacob A.
    Desai, Pujan K.
    Brobey, Reynolds
    Skinner, Sheri
    Dehghani, Mehdi
    Rosenblatt, Kevin P.
    Li, Wenliang
    Amato, Robert J.
    Souza, Glauco R.
    [J]. CANCER RESEARCH, 2016, 76
  • [9] Patient-derived 3D bioprinting pan-cancer drug screening platform for personalized medicine
    Yang, Huiyu
    Zhang, Jiangang
    Shan, Ying
    Wang, Yanan
    Cao, Yaning
    Sun, Yuning
    Jin, Ying
    Pan, Lingya
    Ke, Chunhai
    Cui, Wei
    Yang, Mian
    Zhou, Bo
    Jia, Ziqi
    Cao, Heng
    Wang, Yu
    Ma, Wenbin
    Xu, Xiao
    Zhao, Hai-Tao
    Yang, Huayu
    Mao, Yilei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [10] Patient-derived organoids: 3D miniature models of bladder cancer
    Mastroianni, R.
    Frascolla, C.
    Donzelli, S.
    Orlandi, G.
    Scalera, S.
    Ciuffreda, L.
    Di Martino, S.
    Russo, A.
    Strano, S.
    Costantini, M.
    Blandino, G.
    Simone, G.
    [J]. EUROPEAN UROLOGY, 2024, 85 : S1907 - S1908